The drug maker cut the list price of the drug Repatha by 60 percent in an effort to increase sales, which have been meager.
Published: October 25, 2018 at 02:00AM
from NYT Health https://ift.tt/2Sj05PK
The drug maker cut the list price of the drug Repatha by 60 percent in an effort to increase sales, which have been meager.
Published: October 25, 2018 at 02:00AM
from NYT Health https://ift.tt/2Sj05PK